Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia

Hanny Al-Samkari, César Muñoz, Çağlayan Geredeli, Ippokratis Korantzis, Beatriz González Astorga, Cagatay Arslan, Johnny Francisco Cordeiro Camargo, Florian Scotté, Giuliano Borges, Kejia Wang, Melissa Eisen, David J. Kuter, Gerald A. Soff

Open source

DOI: 10.1056/nejmoa2511882
Published: 2026-03-12
Container: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2511882,
  title = {Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia},
  author = {Hanny Al-Samkari and César Muñoz and Çağlayan Geredeli and Ippokratis Korantzis and Beatriz González Astorga and Cagatay Arslan and Johnny Francisco Cordeiro Camargo and Florian Scotté and Giuliano Borges and Kejia Wang and Melissa Eisen and David J. Kuter and Gerald A. Soff},
  year = {2026},
  journal = {New England Journal of Medicine},
  doi = {10.1056/nejmoa2511882},
  url = {https://doi.org/10.1056/nejmoa2511882}
}

RIS

TY  - JOUR
TI  - Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
AU  - Hanny Al-Samkari
AU  - César Muñoz
AU  - Çağlayan Geredeli
AU  - Ippokratis Korantzis
AU  - Beatriz González Astorga
AU  - Cagatay Arslan
AU  - Johnny Francisco Cordeiro Camargo
AU  - Florian Scotté
AU  - Giuliano Borges
AU  - Kejia Wang
AU  - Melissa Eisen
AU  - David J. Kuter
AU  - Gerald A. Soff
PY  - 2026
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa2511882
UR  - https://doi.org/10.1056/nejmoa2511882
ER  -

APA

Al-Samkari, H., Muñoz, C., Geredeli, Ç., Korantzis, I., Astorga, B. G., Arslan, C., Camargo, J. F. C., Scotté, F., Borges, G., Wang, K., Eisen, M., Kuter, D. J., & Soff, G. A. (2026). Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2511882

Source records

crossref · retrieved 2026-09-27T01:07:13.557Z